- Home
- RNAC vs HRTX Comparison
RNAC vs HRTX Comparison
Compare RNAC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAC | HRTX |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.3M | 148.8M |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RNAC | HRTX |
|---|---|---|
| Price | $6.82 | $0.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $34.00 | $4.50 |
| AVG Volume (30 Days) | 166.1K | ★ 1.9M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,797,000.00 | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $5.60 | $0.74 |
| 52 Week High | $14.56 | $2.61 |
Technical Indicators
Market Signals| Indicator | RNAC | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 55.31 |
| Support Level | $6.54 | $0.74 |
| Resistance Level | $7.81 | $1.41 |
| Average True Range (ATR) | 0.45 | 0.05 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 57.01 | 63.06 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.